OptiNose Inc at Cantor Fitzgerald Global Healthcare Conference Transcript
Good morning, everyone. Thank you very much for joining us at the Cantor Fitzgerald healthcare conference. Up next is a fireside chat with Optinose. We have the CEO, Peter Miller, and the CFO, Keith Goldan.
Questions & Answers
Perhaps maybe just the benefit of everyone in the audience, could you just give us a background on Optinose, high-level company structure, the indications the Company is going after and new products you have?
Sure, Brandon, and thanks very much for having us here. So, we describe Optinose as -- our ambition is to be a leading ENT allergy specialty pharmaceutical company. The Company is built around our first product which uses a very novel delivery system we call exhalation delivery to deliver drug very high and deep in the nasal cavity.
The application that we are using in the ENT allergy space is to treat chronic rhinosinusitis. So,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
